Citations

Clear

6728 citation(s) found for "Li, Mark".

Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis
Weaver, Joel, Rouse, Mark S., Steckelberg, James M., Badley, Andrew D. , Badley, Andrew D

Mayo Clinic

The FASEB Journal | July 30, 2004 | Volume: 18 | Issue: 11 | Pages: 1185-1191

10.1096/fj.03-1230com | PMID 15284218 Get It

ABSTRACT The pathophysiology of sepsis involves excessive lymphocyte apoptosis, which correlates with adverse outcomes, and disordered cytokine production, which may promote host injury. As the protease inhibitor (PI) class of antiretroviral agents is known to prevent apoptosis in vitro, we evaluated their effect on survival, lymphocyte apoptosis, and consequent cytokine production in mice with sepsis induced by cecal ligation and perforation. Mice pretreated with PIs have improved survival (67%; P <0.0005) compared with controls (17%) and a significant (P<0.05) reduction in lymphocyte apoptosis. Even mice receiving therapy beginning 4 h after perforation demonstrated improved survival (50%; P <0.05) compared with controls. PI therapy is also associated with an increase in the Th1 cytokine TNF‐a ( P <0.05) early in sepsis and a reduction in the Th2 cytokines IL‐6 and IL‐10 ( P <0.05) late in sepsis; despite no intrinsic antibacterial effects, PI also reduced quantitative bacterial blood cultures. The beneficial effects of PI appear to be specific to lymphocyte apoptosis, as lymphocyte‐deficient Rag1—/— mice did not experience benefit from treatment with PI. Thus, inhibition of lymphocyte apoptosis by PI is a candidate approach for the treatment of sepsis.— Weaver, J. G. R., Rouse, M. S., Steckelberg, J. M., Badley, A. D. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J. 18, 1185–1191 (2004)
Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature
Dispenzieri, Angela , Moreno‐Aspitia, Alvaro , Suárez, Guillermo A. , Lacy, Martha Q. , Colón‐Otero, Gerardo , Tefferi, Ayalew , Litzow, Mark R. , Kyle, Robert A. , Roy, Vivek , Hogan, William J. , Gertz, Morie A. , Dispenzieri, Angela

Mayo Clinic

Blood | July 27, 2004 | Volume: 104 | Issue: 10 | Pages: 3400-3407

10.1182/blood-2004-05-2046 | PMID 15280195 Get It

Abstract POEMS syndrome is characterized by peripheral neuropathy (PN), a clonal plasma cell disorder (PCD), organomegaly, endocrinopathy, skin changes, edema, sclerotic bone lesions, and thrombocytosis. Based on the improved response rates observed with peripheral blood stem cell transplantation (PBSCT) in patients with other PCDs, autologous PBSCT may be an attractive treatment option for this syndrome. Sixteen patients with POEMS syndrome have undergone PBSCT at Mayo. Of these patients, 15 had a severe rapidly progressive sensorimotor PN (9 were wheelchair dependent) and 14 were male. Median age was 51 years (range, 19-62 years). The median number of prior therapies was 3 (range, 0-7). From first symptoms and from diagnosis of POEMS the times to transplantation were 42 months and 5 months (ranges, 8-185 months and 2-149 months), respectively. There were 15 patients who had significantly abnormal pretransplant pulmonary function tests. There was one transplant-related death. During the peritransplant period, 5 patients required intubation for respiratory compromise, including one who required intubation during his stem cell mobilization period. Another patient required noninvasive biphasic positive airway pressure throughout his course. Of the 14 evaluable patients, all have had neurologic improvement or stabilization. Other features have improved substantially. PBSCT for POEMS syndrome is effective therapy but may also be associated with significant morbidity. (Blood. 2004;104:3400-3407)
Critical evaluation of the different staging systems for hepatocellular carcinoma (Br J Surg 2004; 91: 400-408)
Pawlik, Timothy M. , Lauwers, Gregory Y. , Nagorney, David M. , Curley, Steven A. , Poon, Ronnie T.P., Belghiti, Jacques, Greene, Frederick L. , Henderson, J. Michael, Vauthey, Jean‐Nicolas , Roh, Mark S.

Mayo Clinic

British Journal of Surgery | July 27, 2004 | Volume: 91 | Issue: 8 | Pages: 1072-1072

10.1002/bjs.4782 | PMID 15286973 Get It

Abstract The Editors welcome topical correspondence from readers relating to articles published in the Journal. Responses can be sent electronically via the BJS website (www.bjs.co.uk) or by post. All letters will be reviewed and, if approved, appear on the website. A selection of these will be edited and published in the Journal. Letters must be no more than 250 words in length. Letters submitted by post should be typed on A4-sized paper in double spacing and should be accompanied by a disk.
Hemofiltration but Not Steroids Results in Earlier Tracheal Extubation following Cardiopulmonary Bypass
Oliver, William C., Nuttall, Gregory A. , Orszulak, Thomas A., Bamlet, William R. , Ereth, Mark H. , Schaff, Hartzell V. , Bamlet, William R , Schaff, Hartzell

Mayo Clinic

Anesthesiology | July 23, 2004 | Volume: 101 | Issue: 2 | Pages: 327-339

10.1097/00000542-200408000-00013 | PMID 15277915 Get It

Background Activation of the inflammatory cascade is thought to account for some of the respiratory dysfunction and prolonged mechanical ventilation associated with cardiopulmonary bypass. The objective of this investigation was to identify whether perioperative steroids or hemofiltration during cardiopulmonary bypass, by their attenuation of inflammation, would reduce duration of mechanical ventilation after cardiac surgery. Methods After Institutional Review Board approval and informed consent, 192 patients scheduled to undergo elective primary coronary artery bypass grafting or valvular replacement or repair were randomized in a double-blind prospective study into three groups. One group (Control) received saline at induction and at 6-h intervals for four doses. Another group (Hemofil) received saline and hemofiltration to obtain 27 ml/kg of hemofiltrate. The final group (Steroid) received 1 g methylprednisolone before anesthesia induction and then 4 mg of dexamethasone at 6-h intervals for four doses. All patients underwent normothermic cardiopulmonary bypass and received propofol for postoperative sedation. Separate two-sample comparisons were performed to compare each experimental group versus the control group using the Wilcoxon rank sum test for continuous variables and Fisher exact test for categorical variables. In all cases, two-tailed P values </= 0.05 were considered statistically significant. Results The median time until the patient reached an intermittent mandatory ventilation of 4/min (258.5 versus 385.0 min, respectively; P = 0.02) and tracheal extubation (352.0 versus 518.0 min; P = 0.03) was significantly reduced for group Hemofil but no different for Steroid compared to Control. Conclusions Hemofiltration and steroids are both previously reported to attenuate the inflammatory response but only hemofiltration reduced time to tracheal extubation for adults after cardiopulmonary bypass in this study.
Atypical Tensile-Sided Femoral Neck Stress Fractures
Provencher, Matthew T. , Baldwin, LT Andrew J., Gorman, John D., Gould, Mark, Shin, Alexander Y. , Shin, Alexander Y

Mayo Clinic

The American Journal of Sports Medicine | July 20, 2004 | Volume: 32 | Issue: 6 | Pages: 1528-1534

10.1177/0363546503262195 | PMID 15310582 Get It

FAILURE AFTER PRIMARY RADIATION OR SURGERY FOR PROSTATE CANCER: DIFFERENCES IN RESPONSE TO ANDROGEN ABLATION
Swanson, Gregory P. , Riggs, Mark W., Earle, John D., Swanson, Gregory P

Mayo Clinic

Journal of Urology | July 2, 2004 | Volume: 172 | Issue: 2 | Pages: 525-528

10.1097/01.ju.0000132412.74468.57 | PMID 15247720 Get It

Phase I Trial and Pharmacokinetics of Gemcitabine in Children With Advanced Solid Tumors
Qu, Wenchun , Safgren, Stephanie L. , Ames, Matthew M. , Krailo, Mark , Seibel, Nita L. , Kuttesch, John F., Holcenberg, John S., Reid, Joel M. , Safgren, Stephanie L

Mayo Clinic

Journal of Clinical Oncology | June 15, 2004 | Volume: 22 | Issue: 12 | Pages: 2445-2451

10.1200/jco.2004.10.142 | PMID 15197207 Get It

Purpose To determine the maximum tolerated dose, toxicity, and pharmacokinetics of gemcitabine in children with refractory solid tumors. Patients and Methods Gemcitabine was given as a 30-minute infusion for 2 or 3 consecutive weeks every 4 weeks, to 42 patients aged 1 to 21 years. Doses of 1,000, 1,200 and 1,500 mg/m2 were administered for 3 weeks. Subsequently, gemcitabine was given for only 2 consecutive weeks at 1,500, 1,800, and 2,100 mg/m2. Plasma concentrations of gemcitabine and its metabolite, 2′2′-difluorodeoxyuridine, were measured in 28 patients. Results Forty patients who received 132 courses of gemcitabine were assessable for toxicity. The maximum tolerated dose of gemcitabine given weekly for 3 weeks was 1,200 mg/m2. Dose-limiting toxicity was not seen in one-third of children treated at any doses given for 2 weeks. The major toxicity was myelosuppression in three of five patients at 1,500 mg/m2 for 3 weeks, and one of seven patients at 1,800 mg/m2 for 2 weeks. Other serious adverse events were somnolence, fever and hypotension, and rash in three patients. Gemcitabine plasma concentration–time data were fit to a one- (n = 5) or two-compartment (n = 23) open model. Mean gemcitabine clearance and half-life values were 2,140 mL/min/m2 and 13.7 minutes, respectively. One patient with pancreatic cancer had a partial response. Seven patients had stable disease for 2 to 17 months. Conclusion Gemcitabine given by 30-minute infusion for 2 or 3 consecutive weeks every 4 weeks was tolerated well by children at doses of 2,100 mg/m2 and 1,200 mg/m2, respectively.
Difficulties with the “N + 7 Rule” in endoscopic anterior cruciate ligament reconstruction
Pagnano, Mark W., Kim, Chang-Woo , Huie, Gordon, Pagnano, Mark W. , Scott, W. Norman

Mayo Clinic

Arthroscopy | June 2, 2004 | Volume: 13 | Issue: 5 | Pages: 597-599

10.1016/s0749-8063(97)90186-9 | PMID 9343648 Get It

Abstract In an effort to facilitate the use of interference screw fixation in the tibia, a method to orient the tibial tunnel termed the “N + 7 Rule” was prospectively applied to 60 consecutive endoscopic anterior cruciate ligament reconstructions performed by a single surgeon. Four cases were excluded because a breach in the described protocol for application of the N + 7 rule was identified at the time of the operation. Of the remaining 56 cases, 28 (50%) were fixed with an interference screw on the tibia, whereas 28 (50%) required fixation with sutures tied over a post. The 28 cases not amenable to interference screw fixation included 17 cases in which the tibial tunel was too long and 11 cases in which the tunnnel was too short. It appears that the applicability of the N + 7 rule to an individual surgeon's practice may be altered by small variations in operative technique.
The mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health
Hirsch, Alan T., Gloviczki, Péter , Drooz, Alain , Lovell, Marge, Creager, Mark A. , Gloviczki, Péter

Mayo Clinic

Vascular Medicine | May 28, 2004 | Volume: 9 | Issue: 1 | Pages: 78-86

10.1191/1358863x04vm527xx Get It

There has been increasing recognition of the detrimental impact of peripheral arterial disease (PAD) on the health of Americans, and yet there is no common national program of public PAD education designed to diminish this impact. To heighten awareness of this problem, a 2-day PAD Public Education Strategy Meeting was recently attended by representatives of 17 professional societies and public health associations whose missions support the prevention, diagnosis, treatment, and rehabilitation of vascular diseases. This Public Education Strategy Meeting was intended to provide the rationale and structure to create a national PAD public awareness campaign to diminish the health impact of PAD, and to improve cardiovascular outcomes in the USA. This paper: (1) provides the rationale for creation of a national PAD public education program; (2) reviews the development and success of national hypertension, hypercholesterolemia, and Women’s Heart Health public education programs as models of educational efficacy; (3) elucidates how the work of many vascular professionals has led to a national consensus for creation of a national PAD public educational program; (4) provides an overview of the National Heart, Lung and Blood Institute PAD education meeting; and (5) outlines the ‘next steps’ required to accomplish these goals. This meeting achieved consensus that we share responsibility for developing accurate, unified messages to promote PAD awareness and improved care. Participants agreed that the creation of such messages should be linked to plans to disseminate them to all Americans at risk. A consensus was reached that such messages, when commonly created and offered to the public, are most likely to achieve the rewards in better health that all Americans deserve. The Vascular Disease Foundation, a not-for-profit foundation whose mission includes public education regarding the prevention, diagnosis, treatment, and rehabilitation of PAD, will devote its resources to guide a new coalition in this process and to create a national PAD awareness campaign. During 2003 and 2004, the coalition will create the organizational underpinnings and timeline for what will undoubtedly be a multi-year effort. In conclusion, participants of the Public Education Strategy Meeting agreed to create a broad coalition to develop a national PAD public awareness program, with the objectives to develop and disseminate public education messages on PAD. A successful national PAD education program will contribute to the creation of a broader mandate to improve global cardiovascular health in the USA.
Association of a dynamin-like protein with the Golgi apparatus in mammalian cells.
Henley, John R. , McNiven, Mark A.

Mayo Clinic

The Journal of cell biology | May 15, 2004 | Volume: 133 | Issue: 4 | Pages: 761-775

10.1083/jcb.133.4.761 | PMID 8666662 Get It

Dynamins are a family of 100-kD GTPases comprised of at least three distinct gene products and multiple alternatively spliced variants. Homologies with the shibire gene product in Drosophila melanogaster and with Vps1p and Dnm1p in Saccharomyces cerevisiae suggest that dynamins play an important role in vesicular transport. Morphological studies have localized brain dynamin to coated pits and tubular invaginations at the plasma membrane, where it is believed to facilitate the formation of endocytic vesicles. Because similar membrane-budding events occur at the Golgi apparatus and multiple dynamin isoforms exist, we have studied the distribution of dynamins in mammalian cells. To this end, we generated and characterized peptide-specific antibodies directed against conserved regions of the dynamin family. By immunoblot analysis, these antibodies reacted specifically with a 100-kD protein in fibroblasts that sedimented with membranes and microtubules in vitro in a manner similar to brain dynamin. By immunofluorescence microscopy, these antibodies strongly labeled the Golgi complex in cultured fibroblasts and melanocytes, as confirmed by double labeling with a Golgi-specific antibody. Furthermore, Western blot analysis showed significant enrichment of a 100-kD dynamin band in Golgi fractions isolated from the liver. To substantiate these findings, we use a specific antidynamin antibody to immunoisolate Golgi membranes from subcellular Golgi fractions, as determined by EM and immunoblot analysis. This study provides the first morphological and biochemical evidence that a dynamin-like protein associates with the Golgi apparatus in mammalian cells, and suggests that dynamin-related proteins may have multiple cytoplasmic distributions. The potential contributions of dynamin to the secretory and endocytic pathways are discussed.